FMP
VolitionRx Limited
VNRX
AMEX
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.
0.494 USD
0.034 (6.88%)
VNRX Financial Statements
Year
2024
2023
2022
2021
Total Revenue
1.23M
775.3k
306.39k
90.03k
Cost of Revenue
0
0
1.19M
0
Gross Profit
1.23M
775.3k
-882.03k
90.03k
Operating Expenses
28.26M
36.76M
30.86M
26.9M
Research and Development
14.41M
19.55M
14.57M
15.54M
Selling, General & Administrative Expenses
13.85M
16.92M
17.17M
12.75M
Selling & Marketing Expenses
5.36M
1.01M
1.05M
4.13M
General & Administrative Expenses
8.49M
15.91M
16.11M
8.62M
Other Expenses
0
0
-880.62k
-1.39M
Operating Income
-27.02M
-35.99M
-31.78M
-28.33M
Total Other Income/Expenses Net
57.13k
310.62k
1.18M
1.34M
Income Before Tax
-26.97M
-35.68M
-30.6M
-26.99M
Income Tax
0
0
-329.68k
-19.31k
Net Income
-26.97M
-35.32M
-30.27M
-26.97M
Basic EPS
-0.31
-0.5
-0.55
-0.51
EPS Diluted
-0.31
-0.5
-0.55
-0.51
Basic Average Shares
86.53M
71.23M
55.35M
52.66M
Diluted Average Shares
86.53M
71.23M
55.35M
52.66M
EBITDA
-25.58M
-34.04M
-29.24M
-25.69M
Retained Earning Schedule
Year
2024
2023
2022
2021
Retained Earnings (Previous Year)
-202.58M
-167.26M
-136.99M
-110.17M
Net Income
-26.97M
-35.32M
-30.27M
-26.97M
Stock Repurchases
0
-31.77k
0
0
Dividend Paid
0
0
0
0
Retained Earnings
-229.54M
-202.58M
-167.26M
-136.99M
Other Distributions
-26.97M
-35.35M
-30.27M
-26.81M
PPE Schedule
Year
2024
2023
2022
2021
Gross PPE
5.03M
6.07M
6.01M
5.29M
Annual Depreciation
1.34M
1.41M
1.19M
1.15M
Capital Expenditure
-277.5k
-1.08M
-1.57M
-973.56k
Net PPE
3.97M
5.74M
6.39M
5.12M
Intangible and Goodwill Schedule
Year
2024
2023
2022
2021
Acquisitions and Adjustments
0
0
0
0
Goodwill (Previous Year)
0
0
0
0
Goodwill
0
0
0
0
All figures are in USD.
